Alzheimer's disease trials recruiting in Maryland

All Alzheimer's disease trials nationally

Cities in Maryland

Recruiting trials in Maryland

• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
  NCT07011732 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Maryland: Gaithersburg
• A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
  NCT06937229 · Phase: Phase 3 · Ages: 55 Years to 90 Years · Sex: All (male and female) · Maryland: Gaithersburg
• Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
  NCT06563895 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Maryland: Baltimore
• Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging
  NCT07099053 · Phase: Not specified · Ages: 55 Years to 110 Years · Sex: All (male and female) · Maryland: Baltimore
• Clinical Trial on Agitation in Alzheimer's Dementia
  NCT05543681 · Phase: Phase 2 · Ages: 60 Years and older · Sex: All (male and female) · Maryland: Baltimore, Clinton, Olney
• Cognitive Vulnerability to Stress in Individuals at Risk for Alzheimer's Disease
  NCT05795634 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Crownlands Observing Progression With Neurons Study
  NCT07611396 · Phase: Not specified · Ages: 55 Years and older · Sex: All (male and female) · Maryland: Germantown
• Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline
  NCT05556395 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Maryland: Baltimore
• HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms
  NCT06930560 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 100 Years · Sex: All (male and female) · Maryland: Baltimore
• Medicare Anti-Aβ mAb Coverage With Evidence Development (CED) Study
  NCT06058234 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Maryland: Baltimore
• Music Therapy for Patients With Alzheimer's Disease
  NCT05151562 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 89 Years · Sex: All (male and female) · Maryland: Baltimore
• PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease
  NCT04396873 · Phase: Phase 1 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Maryland: Bethesda
• PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
  NCT07169630 · Phase: Phase 1 · Ages: 50 Years to 100 Years · Sex: All (male and female) · Maryland: Bethesda
• Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
  NCT04123314 · Phase: Early Phase 1 · Ages: 18 Years to 85 Years · Sex: All (male and female) · Maryland: Baltimore
• Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
  NCT06847321 · Phase: Phase 2 · Ages: 55 Years to 80 Years · Sex: All (male and female) · Maryland: Pikesville
• Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone
  NCT05282550 · Phase: Phase 2 · Ages: 55 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Trial of CORT108297 to Attenuate the Effects of Acute Stress in the Allocortex (CORT-X)
  NCT04601038 · Phase: Phase 2 · Ages: 55 Years and older · Sex: All (male and female) · Maryland: Baltimore
• Vestibular Therapy in Alzheimer's Disease
  NCT03799991 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years and older · Sex: All (male and female) · Maryland: Baltimore